An investigation of the effects of fetuin-A on paraquat-induced oxidative injury in renal proximal tubular epithelial cells

Physiology 2012 (Edinburgh) (2012) Proc Physiol Soc 27, PC293

Poster Communications: An investigation of the effects of fetuin-A on paraquat-induced oxidative injury in renal proximal tubular epithelial cells

L. C. Holland1,2, P. K. Chatterjee2

1. Brighton and Sussex Medicial School, Brighton, East Sussex, United Kingdom. 2. Pharmacology and Therapeutics, University of Brighton, Brighton, East Sussex, United Kingdom.

View other abstracts by:


INTRODUCTION: Fetuin-A or α2-Heremans-Schmid glycoprotein (AHSG) is a hepatically synthesised negative acute phase plasma protein belonging to the cystatin superfamily of cysteine protease inhibitors. It acts as a potent inhibitor of vascular calcification (Schafer et al., 2003). Sub-physiological levels of serum fetuin-A are found in patients with chronic kidney disease (CKD) and is associated consequent ectopic vascular calcification (Ketteler et al., 2003). Patients with CKD also have a pro-oxidant milieu which contributes significantly to associated morbidity and mortality. AIM: The aim of this study was to investigate the effects of fetuin-A at a range of physiological and sub-physiological concentrations on oxidant injury caused to renal epithelial cells by the pro-oxidant paraquat, which generates superoxide anions and thereby causes oxidant injury (Samai et al., 2007). METHODS: Confluent cultures of NRK-52E cells, a rat proximal tubular cell-line, were incubated with increasing concentrations of paraquat (0-5 mM) in Dulbecco’s Modified Eagle’s Medium (DMEM) for 24 hours. Cultures were also incubated with fetuin-A (0.01, 0.1 and 1.0 mg/mL) for either 24 hours prior to (pre-incubations) or at the same time as paraquat (co-incubations). Cell viability was assessed via spectrophotometric measurement of the mitochondrial-dependent conversion of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) into formazan. Data are presented as mean % cell viability±S.D., analysed using one-way ANOVA and Bonferroni’s post-testing. RESULTS: Paraquat (PQ) produced a significant reduction in the viability of NRK-52E cells at a concentration of 3 mM (untreated cells: 100.0±3.5% vs. PQ only: 15.9±7.7%, p<0.05, n=6). Co-incubation with fetuin-A at a physiological concentration (1 mg/mL) and paraquat (3 mM) for 24 hours produced a significant reduction in paraquat toxicity (PQ only: 15.9±7.7% vs. PQ+fetuin-A: 33.8±6.2%, p<0.05, n=6). Pre-incubation with fetuin-A (1 mg/mL) for 24 hours also produced a reduction in paraquat toxicity (PQ only: 15.9±7.7% vs. fetuin-A then PQ: 67.5±7.1%, p<0.05, n=6). Pre-incubation with fetuin-A produced a greater effect than co-incubation. A sub-physiological concentration of fetuin-A (0.1 mg/mL) was also able to protect against paraquat toxicity following pre-incubation (PQ only: 15.9±7.7% vs. fetuin-A then PQ: 46.44±.7%, p<0.05, n=6). CONCLUSIONS: These results suggest that physiological and sub-physiological concentrations of fetuin-A can provide significant protection against oxidant injury. Our results demonstrate that pre-incubation is significantly more protective than co-incubation. The cellular mechanisms underlying this renoprotection warrant further investigation.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type